biotech

Sweden's Bioagaia, Into a New Line of Anti-inflammatory Probiotics

Filed in archive Food and Agriculture , Microbiology , Patents and Intellectual Property Rights on April 3, 2006

Sweden's Bioagaia, Into a New Line of Anti-inflammatory Probiotics
Biogaia of Sweden acquired a new patent on certain Lactobacilli strains that could lead to various applications in inflammatory research.

Biogaia's managing director Peter Rothschild believes that this new patent is an important step in developing a new generation of probiotics that are directed at specific indications.

Reuteri, which are not currently available in the market, is one of the strains included in Biogaia's new patent. The company is now looking into Helicobacter pylori, which is associated to gastroenteritis, stomach ulcers and stomach cancer. Biogaia's research indicated that its Reuteri probiotic survived and colonized the human stomach while directly reducing the number of Helicobacter pylori, which in effect reduced the infection.

Photo Credit: [Biogaia]

Source: [NutraIngredients]


Permalink: Sweden's Bioagaia, Into a New Line of Anti-inflammatory Probiotics

Tags: probiotics  biotech  anti  inflammatory  into  anti+inflammatory  sweden+bioagaia  line+anti 

Vote for Sweden's Bioagaia, Into a New Line of Anti-inflammatory Probiotics:

  • Currently 9.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.67 out of 6 vote(s) cast.
 
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Most Popular   Best of   Biotech Hubs and Facilities   Biotech/Science Blogs   Corporate and Industrial News   Diagnostics, Methodologies and Instrumentation   Did you know   Drugs, Vaccines and Therapeutics   Energy, Environment and Ecology   Food and Agriculture   Gene Therapy   Genomics, Proteomics and Bioinformatics   Information About   Meetings and Other Events   Microbiology   Misc   Nanomedicine   Other Biotechnology News   Patents and Intellectual Property Rights   Quick introduction   Stem Cells